User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

Interactions with Platform & by Email *

INTERACTIONS

Unique # Participated *

PARTICIPANTS

Responses Validated *

VALIDATIONS

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definition and Scope of Study.....I-3
Pain Management Pharmaceuticals.....I-3
Pain Management Devices.....I-3
Pain Management Services.....I-3
  
   Pain Management Market to Witness Steady Growth.....II-1
Factors Affecting Pain Management Industry.....II-1
Challenges Faced.....II-1
1$100
   Trends and Issues.....II-2
Future Prospects Bright for Pain Relieving Drug Market.....II-2
Generic Drugs Hog the Limelight.....II-2
Cox II Crisis Tarnishes Industry Growth.....II-2
Novel Therapies to Propel Opioid and Non-Opioid Therapies.....II-2
1$100
   Neuropathic Pain - Still an Underserved Market.....II-31$100
   Cyclin-dependent kinase 5 (Cdk5).....II-4
Drug Dynamics in the Migraine Market.....II-4
1$100
   Pain Pathways – Gain a Second Look.....II-5
Leading Players.....II-5
Generics to Inundate Pain Management Drug Market Further.....II-5
1$100
   Table 1: Leading Players in the Global Pain Management Pharmaceuticals Market (2011): Market Share Breakdown of Value Sales for Pfizer, Eli Lilly, Johnson & Johnson, Endo Pharma, Novartis and Others (includes corresponding Graph/Chart).....II-6
Status of Major Pipeline Drugs for Pain Management.....II-6
1$350
   Pain Management: An Overview.....II-7
Managing Pain.....II-7
What is Pain?.....II-7
Assessment of Pain.....II-7
1$100
   Pain Management.....II-81$100
   Pain Management for Neonates.....II-9
Pain Management in Kids.....II-9
Pain Management in Older Adult Surgical Patients.....II-9
1$100
   Pain Therapeutics – An Introduction.....II-101$100
   Treatment of Pain.....II-11
Pharmacologic Method.....II-11
1$100
   Non-pharmacological Method.....II-12
Invasive Procedures.....II-12
Palliative Care.....II-12
1$100
   Alternative Methods.....II-13
Acupuncture.....II-13
Biofeedback.....II-13
Bioelectromagnetic Therapy.....II-13
1$100
   Biomagnetism and Magnetotherapy.....II-14
Guided Imagery.....II-14
Manual/Massage Therapies.....II-14
Aromatherapy Massage.....II-14
Swedish Massage.....II-14
Deep Tissue Massage.....II-14
1$100
   Neuromuscular Therapy.....II-15
Myofascial Release.....II-15
Manual Lymph Drainage.....II-15
Cranial Sacral Therapy.....II-15
Reflexology.....II-15
1$100
   Naturopathy.....II-16
Relaxation Therapy.....II-16
Transcendental Meditation.....II-16
1$100
   Classification of Pain.....II-17
Acute Pain.....II-17
Postoperative pain.....II-17
Labor pain.....II-17
Visceral pain.....II-17
1$100
   Migraine.....II-18
Treatment of Migraine.....II-18
Chronic Pain.....II-18
Cancer pain.....II-18
1$100
   Back Pain.....II-19
Neuropathic Pain.....II-19
Arthritic Pain.....II-19
1$100
   HIV-Related Pain.....II-20
Diabetic Neuropathy.....II-20
1$100
   Osteo-and Rheumatoid Arthritis Pain.....II-21
Pain Management Products and Services.....II-21
Pain Management Pharmaceuticals.....II-21
Over-the-counter Drugs.....II-21
Acetaminophen.....II-21
Aspirin.....II-21
Ibuprofen.....II-21
1$100
   Ketoprofen.....II-22
Naproxen.....II-22
Pramoxine.....II-22
Counterirritants.....II-22
1$100
   Triethanolamine Salicylate (Trolamine).....II-23
Prescription Drugs.....II-23
Non-steroidal Anti-Inflammatories (NSAIDs).....II-23
Non-opioid Analgesics.....II-23
Opioid Analgesics.....II-23
2$125
   Pain Management Devices.....II-25
Electrical Spinal Cord Stimulators.....II-25
1$100
   Electrical Stimulus Devices.....II-26
Transcutaneous Electric Nerve Stimulators (TENS).....II-26
Patient-Controlled Analgesia Infusion Devices.....II-26
Pain Management Services.....II-26
Home Care/Providence Home Health.....II-26
1$100
   Providence Hospices.....II-27
Pain Management Centers and Clinics.....II-27
Pain Rehabilitation Programs.....II-27
1$100
   OTC Painkillers to Carry Conspicuous Safety Warnings.....II-28
Federal Regulatory Norms of Controlled Substances.....II-28
DEA Regulations.....II-28
1$100
   Venus Remedies to Unveil Aceclofenac OD.....II-29
Sandoz International Launches Metaxalone Tablets in US .....II-29
Covidien Unveils EXALGO™ Extended-Release Tablets.....II-29
1$100
   Bresslergroup Develops Dental Vibe for Pain-Free Dental Injections.....II-30
Competitive Technologies Launches Calmare® Medical Device.....II-30
Victory Pharma Unveils Naprelan Dose Card.....II-30
1$100
   BIOLASE Technology Launches Diolase 10™ Diode Laser .....II-31
Dr. Reddy's Laboratories Unveils Finrid Transdermal Patch.....II-31
Cumberland Pharmaceuticals Unveils Caldolor® in US .....II-31
1$100
   Tenscare Launches Iglove.....II-32
Piramal Launches BioElectronics' ActiPatch in India.....II-32
Victory Pharma to Introduce Supplementary NAPRELAN Products.....II-32
1$100
   Lannett Unveils Two New Products.....II-33
Glenmark Rolls Out Morphine Oral Solution in the US.....II-33
Acrux Introduces New NSAID Formulations.....II-33
Amrutanjan Healthcare Relaunches Amrutanjan Pain Balm.....II-33
ConvaTec Introduces SUR-FIT Natura® Low-Pressure Adaptor.....II-33
Cosman Medical Launches G4 Four-Output RF Generator.....II-33
1$100
   Origin BioMed Unveils Neuragen.....II-34
Biotanika Health Rolls Out Natural Product Range.....II-34
B. Braun Medical Introduces Curlin 6000 CMS.....II-34
Dynatronics Launches DynaPro Spinal Health System.....II-34
ProEthic Pharmaceuticals Unveils Ibudone.....II-34
1$100
   Endo Pharmaceuticals to Introduce New Dosage Strengths of OPANA®ER.....II-35
Dr. Reddy's Laboratories Unveils Supanac.....II-35
Troikaa Pharmaceuticals Rolls Out DYNAPAR AQ 1ml.....II-35
Janssen-Cilag International to Launch IONSYS™.....II-35
1$100
   Mallinckrodt Introduces Novel Pain Relieving Agent.....II-36
Shionogi Unveils Cancer Pain Management Drug.....II-36
NeuroTherm Launches RF Generators for Treatment of Heel Pain.....II-36
McNeil Brings Chewable TYLENOL® GoTabs Tablets.....II-36
1$100
   Barr Unveils Generic Version of ACTIQ®.....II-37
Orthofix Unveils e-PainCare.....II-37
Organon Innovates Org 25969.....II-37
Orthofix’s BREG Division Launches Polar Care Motorized Cold Therapy System.....II-37
Zynex Develops New Pain Management Device.....II-37
1$100
   Grünenthal’s Tapentadol Clears European Decentralised Procedure.....II-38
Stryker to Acquire Pain-Management Device Unit of Boston Scientific.....II-38
Axxess Pharma to Ink License Agreement for a New Prescription Drug.....II-38
Endo Pharmaceuticals Acquires HealthTronics.....II-38
1$100
   Purdue Pharma Secures FDA Approval for Transdermal System.....II-39
Discus Acquisition Takes Over Outstanding Shares of Javelin Pharmaceuticals.....II-39
Cannabis Science to Acquire Montana Pain Management.....II-39
1$100
   Roxro Pharma Receives FDA Approval for SPRIX™ Nasal Spray.....II-40
Ralfinamide Fails to Show Benefits in Phase IIb Trial.....II-40
NeuroTherm Acquires Smith & Nephew's Interventional Spine Pain Management
  Assets.....II-40
Horizon Therapeutics Merges with Nitec Pharma.....II-40
1$100
   Gentiva Takes Over Heart to Heart Hospice.....II-41
Millennium Laboratories Inks National Agreement with Aetna.....II-41
PatientsLikeMe Takes Over ReliefInsite.com.....II-41
1$100
   TeamHealth Hospital Staffing Firm Acquires Anesthetix Management.....II-42
CombinatoRx Merges with Neuromed Pharmaceuticals.....II-42
Roche Licenses P2X31 Receptor Program to Afferent Pharmaceuticals.....II-42
1$100
   Lannett Obtains FDA approval for Producing Hydromorphone Hydrochloride Tablets.....II-43
Anesiva Inks an Asset Purchase Agreement with PowderJect Technologies.....II-43
Millennium Laboratories Inks Agreement with Three Rivers Provider Network.....II-43
Cumberland Pharmaceuticals Partners with Phebra to Promote Caldolor®.....II-43
1$100
   Sciele Pharma Acquires Addrenex Pharmaceuticals.....II-44
Bioniche Pharma Acquires Injectable Drugs from Xanodyne.....II-44
NeurogesX Obtains FDA Approval for Qutenza™.....II-44
1$100
   Cerimon Acquires Development and Commercialization Rights for Diclofenac in
  Europe.....II-45
Hydra Biosciences Collaborates with Cubist.....II-45
Zambon Spa Inks a Licensing Agreement with Indena Spa.....II-45
1$100
   Pfizer Acquires Wyeth.....II-46
B. Braun Bags Contract from HealthTrust Purchasing Group.....II-46
QRxPharma Enters into Partnership with Patheon to Produce Clinical Supplies.....II-46
1$100
   Kimberly-Clark to Acquire I-Flow.....II-47
Kimberly-Clark Takes Over Pain Management Business of Baylis Medical.....II-47
WraSer Pharmaceuticals Purchases Trezix® from e5 Pharma.....II-47
TorreyPines Therapeutics Merges with Raptor Therapeutics.....II-47
1$100
   GSK Enters into Agreement with Dr Reddy's Laboratories.....II-48
Patterson Medical Acquires DJO’s Supply Catalog and Rehabilitation Equipment
  Business.....II-48
Mallinckrodt Acquires Licensing Rights from Neuromed.....II-48
Nuvo Research Enters into Licensing Agreement with Mallinckrodt.....II-48
1$100
   Bederra Plans to Take Over Neogenex.....II-49
Z-Cube Inks Deal with Yissum.....II-49
XenaCare Acquires US License for Homeopathic Treatment.....II-49
Symbios Ropes in Distributors to Market Pain Management Products Across US.....II-49
1$100
   Teikoku Pharma Takes Over Travanti Pharma.....II-50
Diamyd Licenses Endomorphin Technology.....II-50
Competitive Technologies and Life Episteme Enters into an Agreement.....II-50
Bederra Enters into Collaboration with Pain Management Center.....II-50
1$100
   Javelin Pharmaceuticals Signs Agreement with Therabel Pharma.....II-51
Biotanika Inks Deal with Xymogen.....II-51
HSR Clears Solvay Pharmaceuticals and Depomed's Licensing Agreement.....II-51
BioDelivery Sciences and Meda Ink an Agreement.....II-51
Endo Pharmaceuticals to Take Over Indevus Pharmaceuticals.....II-51
1$100
   Actavis US Acquires Kadian.....II-52
Labopharm Receives Approval from U.S. Food and Drug Administration.....II-52
Albert Acquisition Acquires Alpharma.....II-52
Sosei Group Re-acquires Commercialization Rights for AD 923.....II-52
Sun Pharmaceutical Industries Purchases Chattem Chemicals.....II-52
Piramal Healthcare Inks Agreement with Minrad International.....II-52
1$100
   AgION Technologies and Stryker’s Instruments Division Enter into Agreement.....II-53
Elder Pharmaceuticals and Global Energy Medicines Sign Agreement.....II-53
Wound Management Technologies to Take Over BioPharma Management Technologies.....II-53
NovaMed Purchases Stake in The Center for Specialized Surgery.....II-53
1$100
   RxElite Ends Agreement with Minrad International.....II-54
Johnson & Johnson Receives FDA Approval for Tapentadol.....II-54
Mundipharma International and Purdue Pharma Ink Alliance with Infinity.....II-54
Zynex Obtains CE Mark for IF8100 and IF8000 Pain-Managing Devices.....II-54
Competitive Technologies and Able Global Healthcare Ink an Agreement.....II-54
1$100
   National Surgical Hospitals Inks New Joint Venture.....II-55
Getting Ready and Winston Laboratories Merge.....II-55
Competitive Technologies and Biogene Pharma Ink an Agreement.....II-55
MEKT and ProtoKinetix Enter into Agreement.....II-55
Tronics Microsystems Takes Over MedTech Development.....II-55
1$100
   NSC Purchases Ardmore Regional Surgery Center and Kenwood Surgery Center.....II-56
Mallinckrodt and Purdue Pharma Sign Agreement.....II-56
Javelin Pharmaceuticals and Baxter Healthcare Enter into Agreement.....II-56
Competitive Technologies and Excel Life Sciences Ink an Agreement.....II-56
Theragenics to Buy NeedleTech Products.....II-56
1$100
   Wyeth Consumer Healthcare Inks Agreement with Procter & Gamble.....II-57
NovaMed Purchases Majority Stake in Interventional Pain Management Center.....II-57
Option Care Enterprises Takes Over CuraScript Infusion Pharmacy.....II-57
Eli Lilly Obtains FDA Approval for Cymbalta®.....II-57
Curlin Medical Receives Contract from Premier.....II-57
1$100
   EUSA Pharma Acquires Cytogen.....II-58
American Oriental Enters into Alliance with China Aoxing Pharmaceutical.....II-58
Treximet Bags Approval from FDA.....II-58
LMA International Takes Over Breg's Pain Management Operations.....II-58
1$100
   Hospira and HealthTrust Purchasing Group Enter into Agreement.....II-59
Hebei Aoxing Pharmaceutical Purchases Shijiazhuang Lerentang Pharmaceutical.....II-59
Bederra Signs Letter of Intent with Lumar Diagnostic Imaging.....II-59
Integrated Pain Solutions and Devon Health Services Sign Agreement.....II-59
1$100
   Maneesh Pharmaceuticals Purchases Smyle.....II-60
Eli Lilly and Glenmark Pharmaceuticals Ink an Agreement.....II-60
Orexo Takes Over Biolipox.....II-60
ReAble Therapeutics to Acquire Shares of IOMED.....II-60
1$100
   Integra LifeSciences Buys Assets of Pain Management Operations of Physician
  Industries.....II-61
CeNeS Obtains IND Clearance for M6G from FDA.....II-61
Infinity Acquisition Takes Over Life Without Pain.....II-61
1$100
   Neuromed to Acquire US Rights for Oros Hydromorphone from Alza.....II-62
China Aoxing to Acquire Chinese Pharmaceutical Company, Shijiazhuang Le Ren.....II-62
Vyteris Holdings to Acquire Lehigh Valley Technologies.....II-62
1$100
   Younger America Pockets Life Without Pain.....II-63
PainCare Divests Center for Pain Management.....II-63
Grand Slam Acquires IOMED.....II-63
Ligand Accomplishes Divesture of AVINZA.....II-63
CeNeS and Ergomed Collaborate for Phase II Trials of NMDA Antagonist CNS 5161.....II-63
1$100
   Sorenson Secures Approval to Market Ambulatory Infusion Pump in China.....II-64
PainCare Pockets CPMASC.....II-64
Moog Takes Over Mckinley Medical Corp.....II-64
PainCare Acquires REC, CareFirst Medical Associates.....II-64
1$100
   CLL Pharma Acquires Synt:em.....II-65
AstraZeneca Partners with Pozen to Bring Novel Pain Management Therapy.....II-65
Great Outdoors Acquires Somatic Systems Institute.....II-65
PainCare Partners with Solstice Neurosciences to Offer Pain Management in CD.....II-65
Elan Confers Eisai with European Rights of Prialt.....II-65
Evotec Partners with Apeiron Biologics to Bring Novel Pain Therapy.....II-65
1$100
   Alpaca Enterprises Acquires Neuroscience Therapy Corp.....II-66
PainCare Holdings Acquires Desert Pain Medicine Group......II-66
Wex Pharma Inks Agreement With Boston Children’s Hospital.....II-66
Glenmark Inks Agreement with LVT to Market Pain Management Products.....II-66
EKR Attains North American Marketing Rights for Gelclair.....II-66
Grand Slam Acquires Cefar Medical.....II-66
1$100
   Omeros Acquires Nura.....II-67
Hospira Inks Agreement with Premier.....II-67
Pain Therapeutics Enters into Alliance with King Pharmaceuticals.....II-67
Corgentech Merges with AlgoRx.....II-67
Elder Pharmaceuticals Ventures into the Indian Pain Management Market.....II-67
1$100
   Xanodyne Acquires Pharmaceutical Assets of aaiPharma.....II-68
Pro-Dex Acquires Dental Technology From IntraVantage.....II-68
Encore Medical Acquires Compex Technologies.....II-68
Sosei Acquires Arakis.....II-68
Corgentech Signs Definitive Merger Agreement With AlgoRx.....II-68
1$100
   Elder Pharmaceuticals Enters into Marketing Agreement with TRB Chemedica.....II-69
University Pain Management Center Signs Agreement with Somnia.....II-69
Entelos and Organon to Extend Rheumatoid Arthritis (RA) Collaboration.....II-69
NovaMed Establishes a New Pain Management Center at Indiana.....II-69
1$100
   AstraZeneca Plc. (UK).....II-70
Eli Lilly and Company (USA).....II-70
Endo Pharmaceuticals (USA).....II-70
GlaxoSmithkline Plc. (UK).....II-70
1$100
   Johnson & Johnson (USA).....II-71
Merck & Co., Inc. (USA).....II-71
1$100
   Novartis Pharmaceuticals Corp. (USA).....II-72
Pfizer, Inc. (USA).....II-72
Wyeth (USA).....II-72
1$100
   Purdue Pharma (USA).....II-73
Sanofi S.A (France).....II-73
1$100
   Table 2: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-741$350
   Table 3: World Historic Review for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-751$350
   Table 4: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-761$350
   Table 5: World Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-771$350
   Table 6: World Historic Review for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-781$350
   Table 7: World 15-Year Perspective for Pain Management Pharmaceuticals by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-791$350
   Table 8: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-801$350
   Table 9: World Historic Review for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008(includes corresponding Graph/Chart).....II-811$350
   Table 10: World 15-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-821$350
   Table 11: World Recent Past, Current & Future Analysis for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-831$350
   Table 12: World Historic Review for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-841$350
   Table 13: World 15-Year Perspective for Pain Management Services by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-851$350
   A. Market Analysis.....III-1
Pain Statistics in the US.....III-1
Industry Overview.....III-1
1$75
   Pain Management Therapies on the Rise.....III-2
Opioids Pain Management Market to Garner Sizeable Growth.....III-2
Safety Concerns Restrict Large Scale Adoption.....III-2
Measures to Thwart Drug Abuse.....III-2
1$75
   Market for Cancer Pain Therapeutics.....III-3
Leading Players/Brands.....III-3
Table 14: Leading OTC Pain Relievers in the US Market for Pain Management (2011) - Percentage Breakdown of Value Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin Migraine, Private label, and Others (includes corresponding Graph/Chart).....III-3
1$200
   Table 15: Leading Oral Pain Relievers in the US Market for Pain Management (2011) - Percentage Breakdown of Value Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin, Orajel Mouth Aid, and Others (includes corresponding Graph/Chart).....III-41$200
   B. Market Analytics.....III-5
Table 16: The US Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-5
1$200
   Table 17: The US Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-61$200
   Table 18: The US 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (Includes corresponding graphs/chart).....III-71$200
   Market Analytics.....III-8
Table 19: Canadian Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-8
1$200
   Table 20: Canadian Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-91$200
   Table 21: Canadian 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart).....III-101$200
   Market Analytics.....III-11
Table 22: Japanese Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-11
1$200
   Table 23: Japanese Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-121$200
   Table 24: Japanese 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-131$200
   Market Analytics.....III-14
Table 25: European Recent Past, Current & Future Analysis for Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-14
1$200
   Table 26: European Historic Review for Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-151$200
   Table 27: European 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Annual Revenue for France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-161$200
   Table 28: European Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-171$200
   Table 29: European Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed With Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-181$200
   Table 30: European 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart).....III-191$200
   Market Analytics.....III-20
Table 31: French Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-20
1$200
   Table 32: French Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-211$200
   Table 33: French 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-221$200
   Market Analytics.....III-23
Table 34: German Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-23
1$200
   Table 35: German Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-241$200
   Table 36: German 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-251$200
   Market Analytics.....III-26
Table 37: Italian Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-26
1$200
   Table 38: Italian Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-271$200
   Table 39: Italian 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Key Statistics Related to Pain Management in the UK.....III-29
1$75
   B. Market Analytics.....III-30
Table 40: The UK Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-30
1$200
   Table 41: The UK Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-311$200
   Table 42: The UK 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-321$200
   Market Analytics.....III-33
Table 43: Spanish Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-33
1$200
   Table 44: Spanish Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-341$200
   Table 45: Spanish 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-351$200
   Market Analytics.....III-36
Table 46: Russian Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-36
1$200
   Table 47: Russian Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-371$200
   Table 48: Russian 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-381$200
   Market Analytics.....III-39
Table 49: Rest of Europe Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-39
1$200
   Table 50: Rest of Europe Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-401$200
   Table 51: Rest of Europe 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart).....III-411$200
   A. Market Analysis.....III-42
India.....III-42
B. Market Analytics.....III-42
Table 52: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-42
1$200
   Table 53: Asia-Pacific Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-431$200
   Table 54: Asia-Pacific 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-441$200
   Market Analytics.....III-45
Table 55: Latin American Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....III-45
1$200
   Table 56: Latin American Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-461$200
   Table 57: Latin American 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-471$200
   Market Analytics.....III-48
Table 58: Rest of World Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-48
1$200
   Table 59: Rest of World Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-491$200
   Table 60: Rest of World 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-501$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com